Britain’s panel of vaccine advisers on Friday said that people under 40 should be offered an alternative to Oxford/AstraZeneca’s COVID-19 shot where possible, due to a small risk from rare blood clots.
The Joint Committee on Vaccination and Immunisation (JCVI) broadened the age range of people who should be offered alternatives to the Oxford/AstraZeneca to include people aged 30-39. Previously, advice was only for people under 30 to be offered an alternative vaccine.
